SGLT2 Inhibitors Proving Powerful for T2D; Important for Younger Patients?
    April 18, 2019

    SGLT2 Inhibitors Proving Powerful for T2D; Important for Younger Patients?

      We spoke with Naveed Sattar, MD, PhD with the University of Glasgow, Scotland about the Credence Study and its…
    Cardiologist Education Key to Adoption of Advanced T2D Drugs
    April 16, 2019

    Cardiologist Education Key to Adoption of Advanced T2D Drugs

    We corresponded with Felona Gunawan, MD (bio) from the endocrinology department at the Yale School of Medicine and Yale-New Haven…
    Is Muscle Mass the Fountain of Youth?
    April 10, 2019

    Is Muscle Mass the Fountain of Youth?

    We spoke with Angelique (Angie) Brellenthin, a postdoctoral researcher in kinesiology at Iowa State University and co-author of a new…
    ADA Updates Standards to include Vascepa for T2D Cardio Care
    April 9, 2019

    ADA Updates Standards to include Vascepa for T2D Cardio Care

    For 2019, the ADA updated Section 10 of its  Standards of Care based on the published results of the REDUCE-IT study,…
    When is Connected Diabetes Care Intrusive?
    April 4, 2019

    When is Connected Diabetes Care Intrusive?

    Connected care is revolutionizing diabetes management through digital innovation such as wearable sensors and artificial intelligence, aiming to facilitate daily…
    A1c Not Reliable in Diagnosing T2D
    April 2, 2019

    A1c Not Reliable in Diagnosing T2D

    “Based on our findings, A1c should not be solely used to determine the prevalence of diabetes,” said lead researcher Maria…

    Latest News